All In Biotech

Drug Trial Radar · NCT04960202

EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19

AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2/3, DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF-07321332/RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID-19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS

Last checked: Nov 20, 2026Latest source record: Jul 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 2,091 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,091

Actual

Start

Jul 16, 2021

Primary completion

Dec 9, 2021

Study completion Apr 25, 2022

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Jul 13, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether PF-07321332/ritonavir is safe and effective for the treatment of adults who are ill with COVID-19 and do not need to be in the hospital, but are at an increased risk of developing severe illness. Throughout the study period, provision will be made to allow study visits to be conducted at a participant's home or another non-clinic location if available. The total study duration is up to 24 weeks.

Conditions

  • COVID-19

Interventions

  • PF-07321332Drug

    PF-07321332 (tablet)

  • RitonavirDrug

    Ritonavir (capsule)

  • PlaceboDrug

    Placebo (tablet or capsule)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Covid-19 Related Hospitalization or Death From Any Cause Through Day 28- Modified Intent-To-Treat (mITT) PopulationTime frame: From Day 1 to Day 28

Locations

201 sites in 20 countries. Site status is shown where the registry gives one.

  • Cahaba Research Inc

    Pelham, Alabama

  • The Institute for Liver Health dba Arizona Clinical Trials

    Mesa, Arizona

  • The Institute for Liver Health dba Arizona Clinical Trials

    Tucson, Arizona

  • Hope Clinical Research

    Canoga Park, California

  • Ascada Research

    Fullerton, California

  • Atella Clinical Research LLC.

    La Palma, California

  • Ark Clinical Research

    Long Beach, California

  • American Institute of Research

    Los Angeles, California

  • South Bay Clinical Research Institute

    Redondo Beach, California

  • Hope Clinical Research (COVID Satellite Site)

    West Hills, California

  • Future Innovative Treatments, LLC

    Colorado Springs, Colorado

  • Xera Med Research

    Boca Raton, Florida

  • MOORE Clinical Research, Inc.

    Brandon, Florida

  • Innovative Research of West Florida, Inc.

    Clearwater, Florida

  • Herco Medical and Research Center Inc

    Coral Gables, Florida

  • Advance Clinical Research Group

    Cutler Bay, Florida

  • Beautiful Minds Clinical Research Center

    Cutler Bay, Florida

  • Qway Research

    Hialeah, Florida

  • Eastern Research Inc

    Hialeah, Florida

  • Inpatient Research Clinic

    Hialeah, Florida

  • Doral Medical Research LLC.

    Hialeah, Florida

  • Doral Medical Research,LLC

    Hialeah, Florida

  • Unlimited Medical Research Group, LLC

    Hialeah Gardens, Florida

  • Advanced Pulmonary Research Institute

    Loxahatchee Groves, Florida

  • Angels Clinical Research Institute

    Miami, Florida

  • LCC Medical Research Institute, LLC

    Miami, Florida

  • Premium Medical Research Corp

    Miami, Florida

  • Global Health Clinical Trials Corp

    Miami, Florida

  • South Florida Research Center, Inc.

    Miami, Florida

  • Suncoast Research Group, LLC

    Miami, Florida

  • I.V.A.M. Clinical & Investigational Center, LLC

    Miami, Florida

  • C'A Research

    Miami, Florida

  • ProLive Medical Research, Corp.

    Miami, Florida

  • Entrust Clinical Research

    Miami, Florida

  • Reed Medical Research

    Miami, Florida

  • Kendall South Medical Center

    Miami, Florida

  • Clinical Site Partners, Inc d/b/a CSP Miami

    Miami, Florida

  • Coral Research Clinic Corp

    Miami, Florida

  • Savin Medical Group, LLC

    Miami Lakes, Florida

  • Omega Research Orlando, LLC

    Orlando, Florida

Showing 40 of 201 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.